Rwanda vs Zambia: Population requiring preventive chemotherapy for schistosomiasis
Rwanda
5.47 million
in 2024
Zambia
4.79 million
in 2024
Rwanda rank
14th
Zambia rank
17th
Population requiring preventive chemotherapy for schistosomiasis over time
- Rwanda
- Zambia
How they compare
Rwanda currently reports 5.47 million against 4.79 million in Zambia, a difference of 675,670.
That makes Rwanda's figure about 1.1 times Zambia's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Zambia ahead.
Rwanda ranks 14th and Zambia ranks 17th of 52 countries.
Zambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Rwanda | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.64 million | 4.65 million | 3.01 million | Zambia |
| 2020s | 4.32 million | 4.50 million | 180,462 | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Rwanda or Zambia?
- Rwanda, at 5.47 million against 4.79 million in Zambia as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Rwanda and Zambia?
- 675,670, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Zambia?
- 15 years are reported by both, from 2010 to 2024.
- How do Rwanda and Zambia rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Rwanda ranks 14th and Zambia ranks 17th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.